Floatz logo

OSYRITRIN

Hepatitis B Virus Infection

Trieu, Nguyen Thi, M.D.Small moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hepatitis B Virus Infection cohort.

Asset / SponsorPhaseRating
ARG
Trieu, Nguyen Thi, M.D.
Phase 4BB
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Trieu, Nguyen Thi, M.D.
Phase 4BB

Same molecule, other indications

OSYRITRIN is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →